Predict your next investment

Corporation
HEALTHCARE | Medical Devices & Equipment / Device Design & Manufacturing
biosensors.com

See what CB Insights has to offer

Founded Year

1989

Stage

Acq - P2P | Acquired

Revenue

$0000 

About Biosensors International

Biosensors International develops, manufactures and market medical devices used in interventional cardiology and critical procedures. Biosensors has internally developed technology to address each component of a drug-eluting stent system, including a stent, a stent delivery catheter, a biodegradable polymer and a proprietary anti-restenotic drug. It is pursuing three separate drug-eluting stent programs, BioMatrix, Axxion, and BioMatrix Freedom, a polymer-free drug-eluting stent, and has licensed aspects of its drug-eluting stent technology.

Biosensors International Headquarter Location

36, Jalan Tukang

619266,

Singapore

+65 6213 5777

Latest Biosensors International News

06:00 ET Drug-eluting Stent Market to grow by $1.57 Bn | Evolving Opportunities with Abbott Laboratories and Biosensors Internat...

Aug 26, 2021

| Evolving Opportunities with Abbott Laboratories and Biosensors International Group Ltd. | 17000+ Technavio Report News provided by Share this article Share this article NEW YORK, Aug. 26, 2021 /PRNewswire/ -- The drug-eluting stent market value is projected to grow by USD 1.57 billion during 2021-2025. This marks a significant market slowdown compared to the 2020 growth estimates due to the impact of the COVID-19 pandemic in the first half of 2021. However, healthy growth is expected to continue throughout the forecast period, and the market is expected to grow at a CAGR of 4.67%. Latest market research report titled Drug-eluting Stent Market by Type and Geography - Forecast and Analysis 2021-2025 has been announced by Technavio which is proudly partnering with Fortune 500 companies for over 16 years Read the 127-page report with TOC on "Drug-Eluting Stent Market Analysis Report by Type (Polymer free coating and Polymer-based coating) and Geography (North America, Europe, Asia, and ROW), and the Segment Forecasts,2021-2025". Gain competitive intelligence about market leaders. Track key industry opportunities, trends, and threats. Information on marketing, brand, strategy and market development, sales, and supply functions. The drug-eluting stent market is driven by the high prevalence of atherosclerosis. In addition, favorable reimbursement scenarios and reduced risk of contracting restenosis are anticipated to boost the growth of the Drug-Eluting Stent Market. However, one of the foremost factors impeding market growth is the decline in the price of drug-eluting stents. Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free. Polymer free coating - size and forecast 2020-2025 Polymer-based coating - size and forecast 2020-2025 Drug-Eluting Stent Market Geography Outlook (Revenue, USD bn, 2020-2025) North America - size and forecast 2020-2025 Europe - size and forecast 2020-2025 Asia - size and forecast 2020-2025 ROW - size and forecast 2020-2025 Are you a start-up willing to make it big in the business? Grab an exclusive Report Related Reports on Health Care Include: Foot and Mouth Disease Vaccines Market Report -The foot and mouth disease vaccines market have the potential to grow by USD 1.08 billion during 2021-2025, and the market's growth momentum will accelerate at a CAGR of 8.81%. Download a free sample report now! Non-Hodgkin Lymphoma Therapeutics Market Report -The non-Hodgkin lymphoma therapeutics market has the potential to grow by USD 4.51 billion during 2021-2025, and the market's growth momentum will accelerate at a CAGR of 7.96%. Download a free sample report now! About Technavio Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios. Contacts

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Biosensors International

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Biosensors International is included in 1 Expert Collection, including Medical Devices.

M

Medical Devices

3,088 items

Companies that have been granted at least 1 510(k) by the FDA since 2014. Companies tagged as #FDA510(K)

Biosensors International Patents

Biosensors International has filed 9 patents.

The 3 most popular patent topics include:

  • Interventional radiology
  • Vascular diseases
  • Catheters
patents chart

Application Date

Grant Date

Title

Related Topics

Status

3/2/2020

6/29/2021

Transcription factors, Immunosuppressants, Proteins, Human proteins, Macrolides

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

3/2/2020

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

6/29/2021

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Transcription factors, Immunosuppressants, Proteins, Human proteins, Macrolides

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.